Clinical Trial Update: A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With mRCC in Latin America (LA)

View source ↗

Summary

A retrospective medical record review of first-line sunitinib schedules and outcomes in metastatic renal cell carcinoma patients in Latin America; study complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Sunitinib (sunitinib)

Snippet

Sponsor: Pfizer | Conditions: Metastatic Renal Cell Carcinoma ( mRCC) | Status: COMPLETED | Results posted: 2022-05-10